Evidence map›Paper›PMID 30697600›Full record

ArticleJournal of the Endocrine Society2019

The Pituitary Is a Candidate Organ That Modulates Circulating Klotho Levels.

Tetsuhiko Sato, Hirotaka Komaba, Tetsuya Nagatani, Tadashi Watanabe, Yugo Kishida, Masafumi Fukagawa

Open access · goldAbstract read
In one paragraph

Article in Journal of the Endocrine Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Involvement of α-klotho in growth hormone (GH) signaling.Journal of clinical biochemistry and nutrition · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tetsuhiko SatoGeneral Internal Medicine, Nagoya Daini Red Cross Hospital, Nagoya, Japan.ORCID 0000-0002-8343-7982
Hirotaka KomabaDivision of Nephrology, Endocrinology, and Metabolism, Tokai University School of Medicine, Isehara, Japan.
Tetsuya NagataniDivision of Neurosurgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.
Tadashi WatanabeDivision of Neurosurgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.
Yugo KishidaDivision of Neurosurgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan.
Masafumi FukagawaDivision of Nephrology, Endocrinology, and Metabolism, Tokai University School of Medicine, Isehara, Japan.
Japanese Red Cross Nagoya Daini Hospital · JPTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextThe antiaging protein Klotho is shed and released into the blood stream (soluble Klotho). Growth hormone (GH) is considered an active Klotho regulator, because growth retardation is described in Klotho-deficient mice. The origin of circulating Klotho is, however, not fully understood.

objectivesOur objective was to analyze a possible role of the pituitary in regulating soluble Klotho in patients with pituitary adenomas. PATIENTS DESIGN AND

settingWe analyzed serum levels of soluble Klotho, GH, and insulin-like growth factor 1 (IGF-1) from 21 consecutive patients in our center with pituitary tumor, 7 with GH-producing adenomas (GHomas), and 14 with non-GH-producing pituitary adenomas (non-GHomas), before and after endoscopic transsphenoidal surgery (eTSS).

main outcome measureSoluble Klotho levels were determined by ELISA with antihuman Klotho antibodies.

resultsBaseline soluble Klotho levels in all patients, those with GHoma and those with non-GHoma, were 542 (median) (interquartile range: 403, 652), 1083 (425, 1213), and 525 (399, 590), respectively. A drastic reduction in Klotho levels was identified in those with GHoma, accompanied by decreases in GH and IGF-1 levels, after eTSS. Interestingly, patients with non-GHoma had significant declines in soluble Klotho without any significant changes in GH levels. Moreover, an oral glucose tolerance test revealed that soluble Klotho levels decreased, whereas a paradoxical GH peak was observed after glucose intake in a patient with GHoma.

conclusionsOur data suggest that the pituitary may be a key organ that regulates circulating Klotho concentrations, implying that the pituitary possibly controls circulating Klotho through GH-dependent and/or GH-independent mechanisms.

Indexed as

glucose tolerancegrowth hormoneklothopituitary

Identifiers

PMID30697600
PMCPMC6344344
OpenAlexW2900778037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.